(Q37982674)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Juliana Chung-ngor Chan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Xilin Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Wing-Yee So

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Alice P S Kong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Gang Xu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

8 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

Diabetes - Metabolism: Research and Reviews

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

379-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

22 January 2020

cites work

1 reference

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

The Relation between the Cancer and Diabetes Death-rates

21 January 2018

1 reference

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis

21 January 2018

1 reference

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

21 January 2018

1 reference

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

21 January 2018

1 reference

Diabetes mellitus and risk of bladder cancer: a meta-analysis

21 January 2018

1 reference

Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies

21 January 2018

1 reference

Diabetes mellitus and risk of colorectal cancer: a meta-analysis

21 January 2018

1 reference

Diabetes mellitus and risk of breast cancer: a meta-analysis

21 January 2018

1 reference

White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans

21 January 2018

1 reference

Role of inflammation in diabetic nephropathy

21 January 2018

1 reference

Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus

21 January 2018

1 reference

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

21 January 2018

1 reference

Invited commentary: propensity scores

21 January 2018

1 reference

Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry

21 January 2018

1 reference

Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer

21 January 2018

1 reference

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

Metformin and colorectal cancer risk in diabetic patients

21 January 2018

1 reference

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

21 January 2018

1 reference

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

21 January 2018

1 reference

Sulphonylureas and cancer: a case-control study

21 January 2018

1 reference

Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry.

21 January 2018

1 reference

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

21 January 2018

1 reference

From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines

21 January 2018

1 reference

Oxidative stress, inflammation, and cancer: how are they linked?

21 January 2018

1 reference

Insulin-independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice

21 January 2018

1 reference

Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes

21 January 2018

1 reference

Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry.

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

White blood cell count and renin-angiotensin system inhibitors for the risk of cancer in type 2 diabetes

21 January 2018

1 reference

Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study

21 January 2018

1 reference

Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry

21 January 2018

1 reference

The role of high-density lipoprotein in inflammation

21 January 2018

1 reference

Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes

21 January 2018

1 reference

Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy

21 January 2018

1 reference

Fat redistribution and adipocyte transformation in uninephrectomized rats.

21 January 2018

1 reference

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

21 January 2018

1 reference

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

21 January 2018

1 reference

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

Obesity and breast cancer: progress to understanding the relationship.

21 January 2018

1 reference

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

21 January 2018

1 reference

Angiotensin II and the development of insulin resistance: implications for diabetes

21 January 2018

1 reference

Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease

21 January 2018

1 reference

Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.

21 January 2018

1 reference

The renin-angiotensin system and cancer: old dog, new tricks.

21 January 2018

1 reference

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

21 January 2018

1 reference

Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies

21 January 2018

1 reference

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

21 January 2018

1 reference

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals

21 January 2018

1 reference

Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study.

21 January 2018

1 reference

Are large sample size studies the answer to evaluate effects of drug use in non-clinical trial settings?

21 January 2018

1 reference

Angiotensin II revisited: new roles in inflammation, immunology and aging

21 January 2018

1 reference

Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes

21 January 2018

1 reference

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.

21 January 2018

1 reference

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

21 January 2018

1 reference

Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines

21 January 2018

1 reference

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

21 January 2018

1 reference

Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study

21 January 2018

1 reference

Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients

21 January 2018

1 reference

Statins and cancer: A systematic review and meta-analysis

21 January 2018

1 reference

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

21 January 2018

1 reference

Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes

21 January 2018

1 reference

Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.

21 January 2018

1 reference

Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease

21 January 2018

1 reference

Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist

21 January 2018

1 reference

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

21 January 2018

1 reference

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study

21 January 2018

1 reference

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials

21 January 2018

1 reference

Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus

21 January 2018

1 reference

Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

7 January 2021

Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies

1 reference

7 January 2021

Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials)

1 reference

7 January 2021

Blood-pressure drugs and cancer: much ado about nothing?

1 reference

7 January 2021

Insulin glargine and cancer--an unsubstantiated allegation

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.2287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318884%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference